Comparison of Three Therapeutic Strategies for Treating Type 2 Diabetes Mellitus Patients Poorly Controlled With Basal Insulin Associated With Oral Antidiabetic Drugs.
Latest Information Update: 19 Jan 2022
At a glance
- Drugs Insulin glargine (Primary) ; Insulin glulisine (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms OSIRIS
- Sponsors Sanofi
- 16 Sep 2011 Results of a subanalysis presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 20 Sep 2010 Results were presented in an abstract at the 46th Annual Meeting of the European Association for the Study of Diabetes.
- 22 Sep 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.